Innovation

Corneal Endothelial Cell Culture

Schepens Eye Research Institute
posted on 03/04/2009

Human endothelial cells are different from vascular and pulmonary endothelial cells as they have a different tissue origin. Human corneal endothelial cells do not normally proliferate in vivo to replace those lost due to cell injury or death and the growth of these cells in culture is also extremely limited. The new growth method uses an agent that interrupts cell-to-cell contact. In addition, the medium contains growth factors that promote the proliferation of corneal endothelial cells. The new formulation permits the consistent growth of older donor cells which was previously particularly difficult to achieve. The new medium formulation would have a great impact in the field of corneal transplantation to increase the endothelial cell density of donor corneas or to produce artificial corneal constructs. The new formulation can also be used for research purposes, to induce proliferation of ocular cells and non-ocular cells such as sensory neurons.


Innovation Details
 

File Number: SERI-115 

Other Information:

Investigator(s)
Ph.D. Nancy Joyce

Contact
Mary Chatterton, Director of Corporate Alliances. mary.chatterton@schepens.harvard.edu.


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact the case manager at Schepens Eye Research Institute for more information.

Request more info via email request more info
People

No people are currently associated with this innovation.


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

12,576 members 18,785 innovations 176 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...